251 related articles for article (PubMed ID: 31867612)
1. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
Qin B; Xu W; Li Y
Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
[TBL] [Abstract][Full Text] [Related]
2. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
Wang J; Chen R; Li J; Lu X
Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
[TBL] [Abstract][Full Text] [Related]
3. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
Xu W; Li Y
Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
[TBL] [Abstract][Full Text] [Related]
4. The role of staging surgery in the treatment of apparent early-stage malignant ovarian germ cell tumours.
Zhao T; Zhang H; Liu Y; Jiang H; Wang X; Lu Y
Aust N Z J Obstet Gynaecol; 2016 Aug; 56(4):398-402. PubMed ID: 27135780
[TBL] [Abstract][Full Text] [Related]
5. 8-year analysis of the prevalence of lymph nodes metastasis, oncologic and pregnancy outcomes in apparent early-stage malignant ovarian germ cell tumors.
Chatchotikawong U; Ruengkhachorn I; Leelaphatanadit C; Phithakwatchara N
Asian Pac J Cancer Prev; 2015; 16(4):1609-13. PubMed ID: 25743840
[TBL] [Abstract][Full Text] [Related]
6. Are omentectomy and lymphadenectomy necessary in patients with apparently early-stage malignant ovarian germ cell tumors?
Qin B; Xu W; Li Y
Int J Gynecol Cancer; 2019 Feb; 29(2):398-403. PubMed ID: 30674572
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary.
Mahdi H; Swensen RE; Hanna R; Kumar S; Ali-Fehmi R; Semaan A; Tamimi H; Morris RT; Munkarah AR
Br J Cancer; 2011 Aug; 105(4):493-7. PubMed ID: 21772335
[TBL] [Abstract][Full Text] [Related]
8. Trends in the surgical management of malignant ovarian germcell tumors.
Nasioudis D; Mastroyannis SA; Latif NA; Ko EM
Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791
[TBL] [Abstract][Full Text] [Related]
9. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
[TBL] [Abstract][Full Text] [Related]
10. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
[TBL] [Abstract][Full Text] [Related]
11. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909
[TBL] [Abstract][Full Text] [Related]
13. Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy.
Nasioudis D; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Burger RA; Morgan MA; Latif NA
Gynecol Oncol; 2020 Jun; 157(3):613-618. PubMed ID: 32359845
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Lymphadenectomy in Different Stages of Malignant Germ Cell Tumor of the Ovary Based on Propensity Score Matching.
Chen Y; Ning Y; Zhang Q; Xie Y
Comb Chem High Throughput Screen; 2018; 21(9):652-661. PubMed ID: 30569854
[TBL] [Abstract][Full Text] [Related]
15. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
16. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
[TBL] [Abstract][Full Text] [Related]
17. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
18. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.
Topuz S; Iyibozkurt AC; Akhan SE; Keskin N; Yavuz E; Salihoglu Y; Bengisu E; Berkman S
Eur J Gynaecol Oncol; 2008; 29(6):635-7. PubMed ID: 19115694
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and prognostic factors of patients with recurrent and persistent malignant ovarian germ cell tumors.
Wang J; Zhuo X; Yang J; Cao D; Shen K; Huang H; Wu M; Pan L; Xiang Y; Guo L
Arch Gynecol Obstet; 2020 Apr; 301(4):1021-1026. PubMed ID: 32198624
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
